SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is rallying as investors react to potential U.S. government crypto holdings and favorable macro conditions, fueling a massive short squeeze that pushed the price above key technical resistance levels. Community sentiment is sharply divided between bulls celebrating a breakout from the bear cycle and skeptics warning that this surge may serve as exit liquidity for a future pullback.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares are surging following positive Phase 3 clinical trial results for its personalized mRNA melanoma vaccine developed in partnership with Merck. While bulls view this as a transformative breakthrough for the company's oncology pipeline, skeptics are actively debating the long-term path to commercialization and voicing concerns about potential dilution or overvaluation.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is surging following a record-breaking second quarter that beat earnings and revenue expectations, fueled by a significant increase in trading activity and successful international expansion. The community is actively debating the potential for a short squeeze, with many retail investors expressing optimism about the stock reaching double digits while others advise caution due to historical volatility surrounding options expiration.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending as traders speculate on a potential market recovery fueled by shifting macro conditions, upcoming regulatory meetings, and institutional interest. The community remains divided, with many actively debating whether this is a genuine breakout or a temporary squeeze before further volatility.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is seeing heavy volatility as the stock continues to decouple from Bitcoin's momentum, with community members heavily debating the impact of ongoing share dilution against the backdrop of a broader crypto sector rally. While bulls point to upcoming political catalysts and positive macro signals, bears are actively targeting the stock, citing aggressive capital-raising activities and the firm's reliance on complex financial structures to support its balance sheet.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is seeing heightened momentum as investors react to bullish crypto-macro sentiment, aggressive share buybacks, and persistent expectations surrounding potential regulatory progress. Community discussion remains polarized, with vocal longs betting on a significant short squeeze fueled by institutional treasury growth and ETH-linked upside, while critics continue to express frustration over long-term price underperformance and management strategy.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors pivot toward cancer vaccine plays following positive late-stage trial news from Moderna, fueling speculation about potential institutional interest and a possible short squeeze given the stock's elevated short interest. Community sentiment is highly optimistic, with bulls closely monitoring the imminent Phase 3 REGAL trial data as a major valuation catalyst while bracing for potential volatility.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck & Co. is experiencing a surge in investor attention following positive late-stage clinical data for its personalized mRNA cancer vaccine, developed in partnership with Moderna. The community is actively debating the broader implications of this breakthrough for the mRNA oncology platform and assessing whether Merck is effectively positioning its pipeline for long-term growth as it navigates the competitive landscape for its core oncology treatments.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is currently under intense pressure as the 30-year Treasury yield hits levels not seen since 2007, prompting active community debate over whether government intervention through increased bond buybacks can provide a floor or if macro factors like persistent inflation and deficit spending will continue to drive yields higher. Traders are closely monitoring upcoming CPI data, with many expressing concern that the bond market is signaling a deeper fiscal crisis that is decoupling from the stock market's AI-driven optimism.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as shareholders weigh optimistic guidance and an earnings beat against concerns over patent cliffs and the long-term impact of its vaccine division. The community remains divided, with some investors accumulating shares for the consistent dividend yield while others express frustration over the stock's multi-year sideways performance and leadership's strategic direction.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

They had to go purfect MNDY Thursday 🐑 low in $HRMY  n soon da cup n handles shall bust out in $RYTM ENTA 🐒🍌🧠⏰♾️

Nicholas

Vkvk

Chris Gold

Bahhh FRYday afterhours close is in $HRMY ENTA 🐒🍌🧠⏰♾️

StockTwits for iOS

Harmony Biosciences Holdings Inc

Rhythm Pharmaceuticals Inc.

They had to go purfect MNDY Thursday 🐑 low in 

  n soon da cup n handles shall bust out in 

@Doozio  bro, give me the real scoop on what happened to McGregor at his last UFC fight! 😭￼

$TSLA  didn’t yo wUtch? Or listen to conference call.  Bums. 

❤️👑🌈🦄

  bro, give me the real scoop on what happened to McGregor at his last UFC fight! 😭￼